• The Top 5 Innovations Improving Efficiency in Today’s Retina Practice

    The authors’ choices of the latest innovations that help keep clinics and…

    Read Article
  • Reporting MIPS in 2018

    What Retina Specialists Must Know to Maximize Bonus Potential and Avoid Penalties

    Read Article
  •  
     
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • ZEISS OCT Angiography eNewsletter Series
  • AMD Disease Education Resource Center
  • AMD Disease Education Resource Center
  • Articles From This Issue

     

    UP FRONT

    Chief Medical Editor’s Page

    Focus on the Positive

    There’s no denying that 2017 wasn’t the best of years. Hurricanes, wildfires, and floods affected residences, businesses, and health care facilities, including some…

    Retina News

    FDA APPROVES FIRST GENE THERAPY FOR PATIENTS WITH INHERITED RETINAL DISEASE By Stephen Daily, Executive Editor, News In December, Spark Therapeutics received US Food and …

    Medical Update

    General Health High Rate of Future Adult Obesity Projected by Simulation Models Given the current level of childhood obesity in the United States, a simulation study pred…

     

    Supplements and Inserts

    Supplement

    Continuous Innovations in Retina

    CME-1 Credit

    AMD in 2017: A Review of Treatment Guidelines and the Role of Early Appropriate Therapy

    CME-1 Credit

    Treatment Paradigms in AMD Management: Assessing Consistent Long-Term Dosing

    NEWS


     

    Second Sight Announces Market Entry into Singapore with First Implant of Argus II Retinal Prosthesis System

    Second Sight Medical Products announced market entry into Singapore, with the first patient implanted with the Company’s Argus II Retinal Prosthesis System. The implantation was facilitated by t…

    Anti-VEGF Agents Improve Vision Despite Ongoing Diabetic Macular Edema

    In patients with diabetic macular edema (DME), aflibercept and ranibizumab are more effective than bevacizumab in preventing disease persistence, but each drug can lead to substantial gains in vision,…

    Award Winning Algorithm Could Improve Accuracy and Speed of Diagnosis of Retinal Disease

    A new technique for identifying and diagnosing damage to the human retina has been awarded ‘Best Student Paper’ at the industry-leading BIOIMAGING 2018 conference in Portugal, according to…

    Phase 2 Data Support Potential for Novel Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody, RG7716, for People with DME

    Genentech announced encouraging results from the phase 2 BOULEVARD study. In people with vision loss from diabetic macular edema (DME), treatment with intravitreal RG7716 demonstrated clinically meani…

    Featured Content


    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Karen Roman
    Editor-in-Chief
    484-581-1827
    kroman@bmctoday.com

    Janet Burk
    Publisher
    214-394-3551
    jburk@bmctoday.com

    About Retina Today

    Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.